FibroBiologics, Common Company Top Insiders
| FBLG Stock | 1.04 0.06 5.45% |
FibroBiologics, Common employs about 10 people. The company is managed by 6 executives with a total tenure of roughly 24 years, averaging almost 4.0 years of service per executive, having 1.67 employees per reported executive. Examination of FibroBiologics, Common's management performance can provide insight into the company performance.
FibroBiologics, |
FibroBiologics, Common Management Team Effectiveness
The company has return on total asset (ROA) of (0.6577) % which means that it has lost $0.6577 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (2.6786) %, meaning that it created substantial loss on money invested by shareholders. FibroBiologics, Common's management efficiency ratios could be used to measure how well FibroBiologics, Common manages its routine affairs as well as how well it operates its assets and liabilities.FibroBiologics, Common Workforce Comparison
FibroBiologics, Common Stock is one of the top stocks in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 267,671. FibroBiologics, Common adds roughly 10.0 in number of employees claiming only tiny portion of equities under Health Care industry.
FibroBiologics, Common Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific FibroBiologics, Common insiders, such as employees or executives, is commonly permitted as long as it does not rely on FibroBiologics, Common's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, FibroBiologics, Common insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Ruben Garcia over two months ago Acquisition by Ruben Garcia of 176200 shares of FibroBiologics, Common at 2.36 subject to Rule 16b-3 | ||
O'heeron Pete over three months ago Disposition of 100000 shares by Oheeron Pete of FibroBiologics, Common subject to Rule 16b-3 | ||
O'heeron Pete over three months ago Disposition of 50000 shares by Oheeron Pete of FibroBiologics, Common subject to Rule 16b-3 | ||
Niklas Victoria Ninon Olivia over a year ago FibroBiologics Common exotic insider transaction detected | ||
Cilento Richard C Jr over a year ago FibroBiologics Common exotic insider transaction detected |
FibroBiologics, Common Notable Stakeholders
A FibroBiologics, Common stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as FibroBiologics, Common often face trade-offs trying to please all of them. FibroBiologics, Common's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting FibroBiologics, Common's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Peter OHeeron | Chairperson Founder | Profile | |
| CPA BBA | Interim Director | Profile | |
| Ruben JD | General Counsel | Profile | |
| Hamid Khoja | Chief Officer | Profile | |
| CFA CPA | Chief Officer | Profile | |
| Ruben Garcia | General Counsel | Profile |
About FibroBiologics, Common Management Performance
The success or failure of an entity such as FibroBiologics, Common often depends on how effective the management is. FibroBiologics, Common management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of FibroBiologics, management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the FibroBiologics, management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
FibroBiologics, Common Workforce Analysis
Traditionally, organizations such as FibroBiologics, Common use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare FibroBiologics, Common within its industry.FibroBiologics, Common Manpower Efficiency
Return on FibroBiologics, Common Manpower
| Revenue Per Employee | 0.0 | |
| Revenue Per Executive | 0.0 | |
| Net Loss Per Employee | 1.6M | |
| Net Loss Per Executive | 2.7M | |
| Working Capital Per Employee | 3.2K | |
| Working Capital Per Executive | 5.3K |
Complementary Tools for FibroBiologics, Stock analysis
When running FibroBiologics, Common's price analysis, check to measure FibroBiologics, Common's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy FibroBiologics, Common is operating at the current time. Most of FibroBiologics, Common's value examination focuses on studying past and present price action to predict the probability of FibroBiologics, Common's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move FibroBiologics, Common's price. Additionally, you may evaluate how the addition of FibroBiologics, Common to your portfolios can decrease your overall portfolio volatility.
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |